期刊文献+

不同剂量右美托咪定复合舒芬太尼用于纤维肠镜的临床研究 被引量:1

Clinical Study of Different Doses of Dexmedetomidine Combined with Sulfentanil Used for Analgesic Enteroscopy
下载PDF
导出
摘要 目的观察不同剂量的右美托咪定联合舒芬太尼用于纤维肠镜检查术的效果。方法80例ASAⅠ~Ⅱ级行肠镜检查的患者,按右美托咪定负荷剂量不同,随机分为D1组(0.25μg/kg),D2组(0.5μg/kg),D3组(0.75μg/kg)和C组(0μg/kg),每组20例。静脉泵注右美托咪定负荷剂量,给药时间为10min,接着缓慢静脉给予舒芬太尼O.2μg瓜g,检查中DEX以0.5μg/(kg·h)速率持续输注至检查完毕。观察两组患者注药前(1、0)、进入乙状结肠曲(T1)、过脾曲时(112)、过肝曲时(T3),过回盲部(T4)及苏醒时(T5)HR、RR、MAP、SpO:的变化,记录麻醉镇痛效果、Ramsay镇静评分及不良反应发生率。结果与C组及T0时比较,D1、D2和D3组HR在T1~T5时均下降,Ramsay评分增加,与c组比较,D1-D3镇痛效果明显好于c组(P〈0.01)。结论给予右美托咪定负荷剂量O.75μg/kg后,以0.5μ/(kg·h)速率维持,可以安全用于无痛纤维结肠镜检查且麻醉效果满意。 Objective To evaluate the efficacy of different doses of dexmedetomidine combined with sulfentanil used for analgesic enteroscopy. Methods According to loading dose of dexmedetomidine, 80 patients of ASA Ⅰ - Ⅱ undergoing analgesic enteroscopy were randomly divided into 4 groups, group C (0μg/kg), group DI( 0.25 μg/kg), group D2(0.5 μg/kg) and group D3(0.75 μg/kg) with 20 patients in each. They were administered with 0 (control) ,0.25,0.5 and 0.75 g/kg of dexmedetomidine.Intravenous infu- sion of dexmedetomidine loading dose was started within 10 min, followed by slow intravenous infusion of sufentanil 0.2 Ixg/kg, fol- lowed by a continuous infusion of dexmedetomidine 0.5 Ixg/(kg.h) to the end of the operation.The scale of anesthetic effect, HR, MAP, SpO2,Ramsay score and adverse effects were recorded before anesthesia (TO), passing the sigmoid (T1), passing the splenic flexure(T2), passing the hepatic flexure(T3),passing the ileocecal (T4) and awake(T5). Results Compared with the values before administration and in control group,HR of patients in 0.25 Ixg.kgl(D1) , 0.5 μg·kgl(D2), 0.75μg·kg(D3) decreased after dosing and the end of operation. Ramsay score increased after dosing and the end of operation. The analgesic effect in D1-D3 group was better than that in the C group(P〈0.01). Conclusion The loading dose (0.75 μg/kg) of dexmedetomidine combined sulfentanil,fol- lowed by a continuous infusion of 0.5 μg/(kg.h) ,the anesthetic effect for patients undergoing enteroscopy is satisfactory and safe.
作者 褚天 江伟航
出处 《中外医疗》 2013年第30期47-49,共3页 China & Foreign Medical Treatment
关键词 纤维结肠镜检查 无痛 右关托咪定 舒芬太尼 Enteroscopy Analgesic Dexmedetomidine Sulfentanil
  • 相关文献

参考文献12

  • 1章云海,曾因明,雷玲,赵志斌,孔庆云,葛洋,于爱玲,赵琳,朱珊珊,李小明,颜明.皮内注射局麻药对结肠镜检查患者的镇痛效应[J].中华麻醉学杂志,2004,24(8):640-640. 被引量:28
  • 2Yildiz M,Tavlan A,Tuncer S,et al.Effect of dexmedetomidine on haemodynamics and anesthetic requirements[J].Drugs RD,2006,7(1):43-52.
  • 3Cooper L,Candiotti K,Gallagher C,et al.A randomized,controlled trial on dexmedetonidine providing dequate sedation and hemodynamic control for awake,diagnostic transesophageal echocardiography[J].J Cardiothorac Vasc Anesth,2011,25:233-237.
  • 4Cardiotti KA,Bergess SD,Bokesch PM,et al.Monitored anesthesia care with dexmedetomidine:a prospective,randomized,double-blind,multicenter trial[J].Anesth Analg,2010,110:47-56.
  • 5Demiraran Y,Korkut E,Tamer A,et al.The comparison of dexmedetomidine and midazolam used for sedation of patients during upper endoscopy:a prospective,randomized study[J].Can J Gastroenterol,2007,21:25-29.
  • 6Vazquez-Reta JA,Jimenez Ferrer MC,Colunga-Sanchez A,et al.Midazolam versus dexmedetomidine for sedation for upper gastrointestinal endoscopy[J].Rev Gastroenterol Mex,2011,76(1):13-18.
  • 7Demiraran Y,Korkut E,Tamer A,et al.The comparison of dexmedetomidine and midazolam used for sedation of patients during upperendoscopy:A prospective,randomized study[J].Can J Gastroenterol,2007,21(1):25-29.
  • 8吴安石,黄宇光,徐庆,米卫东,袁维秀,岳云.国产舒芬太尼用于术后静脉自控镇痛的疗效和安全性——多中心、随机、双盲、平行对照临床研究[J].国际麻醉学与复苏杂志,2009,30(3):193-195. 被引量:32
  • 9张燕,郑利民.右美托咪啶的药理作用及临床应用进展[J].国际麻醉学与复苏杂志,2007,28(6):544-547. 被引量:224
  • 10Ebert TJ,Hall JE,Barney JA,et al.The effects of increasing plasma concentrations of dexmedetomidine in humans[J].Anesthesiology,2000,93(2):382-394.

二级参考文献30

  • 1佘守章.新型阿片类药物在病人自控镇痛中的应用[J].麻醉与监护论坛,2005,12(1):34-39. 被引量:39
  • 2史明仪,周华珠,蒋志根.豚鼠在体肠系膜下神经节细胞兴奋的来源[J].生理学报,1995,47(3):301-304. 被引量:9
  • 3方先海,张瑞芹.舒芬太尼及其术后自控静脉镇痛的应用[J].中国临床康复,2006,10(2):153-155. 被引量:49
  • 4闫春伶,左明章.不同背景量舒芬太尼用于术后患者静脉自控镇痛[J].医药导报,2006,25(11):1152-1154. 被引量:10
  • 5Ahonen J,Olkkola KT,Hynynen M,et al.Comparison of allentanil,fentanyl and sufentanil for total intravenous anaesthesia with propofol in patients undergoing coronary artery bypass surgery.Br J Anaesth,2000,85(2):533-540.
  • 6Thomson IR,Harding G,Hudson RJ,et al.A comparison of fentanyl and sufentanil in patients undergoing coronary artery bypass graft surgery.J Cardiothorae Vase Anesth,2000,14(6):652-656.
  • 7Sturaitis MK, Braverman B, Tuman KJ. Effect of dexmedetomidine on somatosensory evoked potentials in patients during craniotomy. Anesthesiology, 2003 (abstr) , 99 :A291.
  • 8Paris A, Mantz J, Tonner PH, et al. The effects of dexmedetomidine on perinatal excitotoxic brain injury are mediated by the [ alpha]2A - adrenoceptor subtype. Anesthesia & Analgesia, 2006, 102:456-461.
  • 9Dahmani S, Rouelle D, Gressens P, et al. Effects of dexmedetomidine on hippocampal focal adhesion kinase tyrosine phosphorylation in physiologic and ischemic conditions. Anesthesiology, 2005, 103:969- 977.
  • 10Taniguehi T, Kidani Y, Kanakura H, et al. Effects of dexmedetomidine on mortality rate and inflammatory, responses to endotoxin - induced shock in rats. Critical Care Medicine, 2004, 32:1322-1326.

共引文献279

同被引文献7

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部